To cure, to care,
to make aware.

FightMND invests a further $10.7M in the fight against MND

The fight against Motor Neurone Disease (MND) has received a multi-million-dollar boost with FightMND announcing a further $10.7 million investment into research and care equipment for people living with MND.

This major funding commitment takes the total amount the charity has invested into research and care to more than $63 million since it began in 2014.

How we invest in MND research

To turn research into treatments for MND, FightMND invest in all stages of the research pipeline.

We can think of the research pipeline like a challenging race course and each new potential treatment is a competitor. Hear how your on-going support helps to advance new competitors through the stages of the race, towards new treatments and a cure for MND

Neale's Speech

With lockdowns impacting so many
of us right now, what better time to hear from the man who taught us what it is to 'Play On'?

Every year, Neale gives an inspirational speech to the Melbourne and Collingwood Football Clubs. This year, with son Ben, Neale also shared his wisdom with West Coast and Essendon.

FIGHTMND BOARD

Mike Schneider steps into the role of FightMND Chair

FightMND is pleased to announce Mike Schneider, Managing Director of the Bunnings Group, as our new Board Chair. 

Mike will take over from Bill Guest, who after more than three years is stepping down as Chair but will remain an active member of the FightMND Board.

Read more
What are we fighting for?

We are fighting to beat 'The Beast'

Our vision is a world without Motor Neurone Disease (MND) and it takes an army of people to help achieve this.

Our core aims are to generate greater awareness of the disease, to fund world-class research and drug trials to find an effective treatment and ultimately a cure for MND and provide assistive care equipment to many Australians fighting the disease.

There is no known cause, limited knowledge of the natural course of the disease, there is no effective treatment and there is no cure.

We call it ‘The Beast’. This is why we fight.

$55.9m

Committed to MND research initiatives

$7.3m

in care equipment for people living with MND

$14.3m

committed to 12 Clinical Trials

$21.5m

committed to 22 drug development projects

$4.5m

World-first drug screening platform

$3.2m

19 other research grants & initiatives

$2.6m

Sporadic ALS Australian - Genomics Consortium

$2m

Precision Medicine Program

$6.2m

committed to 25 IMPACT grants

$1.6m

funding 5 research fellowships and scholarships

The Journey Of Your Donation

Our Partners

Our MND stories - meet Terry Roles

Tasmanian Terry Roles was diagnosed with MND in 2019 and he shares his story here